Stocks › PRAX

Praxis Precision Medicines, Inc.

PRAX·Nasdaq·United States United States·USD
$300.43
-10.47 (-3.37%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
PRAX
Praxis Precision Medicines, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
PRAXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of PRAX by members of U.S. Congress · 2 on record · 2 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA PRAXPraxis Precision Medicines, Inc. · Stock Purchase
$1,001 - $15,000
Oct 12, 2026 Sep 29, 2026 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA PRAXPraxis Precision Medicines, Inc. · Stock Purchase
$1,001 - $15,000
Sep 4, 2026 Jul 30, 2026 Filing ↗

Whale Activity

Position changes in PRAX reported for 2026-09-30 by 381 institutional filers
Increased: 129New: 69Held: 38Decreased: 91Closed: 42No prior filing: 12
  • Increased129
  • New69
  • Held38
  • Decreased91
  • Closed42
  • No prior filing12
FilerSharesValueChange
Janus Henderson Group Ltd.3.4M$1.00B—
FMR LLC2.6M$768.2Mincreased
BlackRock, Inc.2.2M$650.3Mdecreased
PERCEPTIVE ADVISORS LLC2.0M$589.7Mdecreased
BAKER BROS. ADVISORS LP1.8M$510.6Mheld
Orbis Allan Gray Ltd1.4M$396.1Mdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC1.3M$380.0Mdecreased
VANGUARD CAPITAL MANAGEMENT LLC1.2M$357.9Mdecreased
STATE STREET CORP1.0M$304.1Mincreased
ADAGE CAPITAL PARTNERS GP, L.L.C.981.5K$285.8Mdecreased
DEERFIELD MANAGEMENT COMPANY, L.P.963.4K$280.6Mheld
BANK OF AMERICA CORP /DE/890.6K$259.4Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by PRAX insiders, by quarter · Form 4
-50.0K-25.0K025.0K50.0K2025 Q1: 02025 Q12025 Q2: 02025 Q22025 Q3: 02025 Q32025 Q4: -38.7K2025 Q42026 Q1: 02026 Q12026 Q2: -11.6K2026 Q22026 Q3: 02026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

199 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Souza MarcioChief Executive Officer · Director Gift −2,600 $0.00 $0 Jul 8, 2026 Form 4 ↗
Souza MarcioChief Executive Officer · Director Gift −20.5K $0.00 $0 Jul 8, 2026 Form 4 ↗
DeSimone JillDirector Sale −837 $315.71 $264K Jun 24, 2026 Form 4 ↗
DeSimone JillDirector Sale −1,279 $314.90 $403K Jun 24, 2026 Form 4 ↗
DeSimone JillDirector Sale −504 $313.66 $158K Jun 24, 2026 Form 4 ↗
DeSimone JillDirector Sale −1,004 $312.83 $314K Jun 24, 2026 Form 4 ↗
DeSimone JillDirector Sale −2,854 $311.91 $890K Jun 24, 2026 Form 4 ↗
DeSimone JillDirector Sale −1,750 $310.89 $544K Jun 24, 2026 Form 4 ↗
DeSimone JillDirector Sale −999 $309.38 $309K Jun 24, 2026 Form 4 ↗
DeSimone JillDirector Sale −1,240 $308.24 $382K Jun 24, 2026 Form 4 ↗
DeSimone JillDirector Sale −683 $306.77 $210K Jun 24, 2026 Form 4 ↗
DeSimone JillDirector Sale −320 $305.31 $98K Jun 24, 2026 Form 4 ↗
DeSimone JillDirector Sale −120 $303.13 $36K Jun 24, 2026 Form 4 ↗
DeSimone JillDirector Sale −10 $301.44 $3K Jun 24, 2026 Form 4 ↗
DeSimone JillDirector Option exercise +3,034 $147.30 $447K Jun 24, 2026 Form 4 ↗
DeSimone JillDirector Option exercise +8,566 $44.25 $379K Jun 24, 2026 Form 4 ↗
Arbuckle Stuart ADirector Grant / award +1,371 $0.00 $0 Jun 10, 2026 Form 4 ↗
Chodakewitz JeffreyDirector Grant / award +1,371 $0.00 $0 Jun 10, 2026 Form 4 ↗
YOUNG WILLIAM DDirector Grant / award +1,371 $0.00 $0 Jun 10, 2026 Form 4 ↗
DeSimone JillDirector Grant / award +1,371 $0.00 $0 Jun 10, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding PRAX · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
885.4K$296.4M0.01%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
653.1K$218.7M0.26%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
639.6K$214.1M0.11%Jun 30, 2026
Select Biotechnology Portfolio
Fidelity Select Portfolios
411.4K$144.1M2.29%Aug 31, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF
SPDR SERIES TRUST
413.7K$138.5M1.29%Jun 30, 2026
VANGUARD SMALL-CAP VALUE INDEX FUND
VANGUARD INDEX FUNDS
405.0K$135.6M0.20%Jun 30, 2026
Janus Henderson Global Life Sciences Fund
Janus Investment Fund
379.4K$127.0M2.19%Jun 30, 2026
Janus Henderson Enterprise Fund
Janus Investment Fund
358.1K$119.9M0.54%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
300.9K$100.7M0.10%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
274.8K$84.6M0.25%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list PRAX's shares (CUSIP 74006W207), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Allan Gray Australia Pty LtdSCHEDULE 13G/A · passive (13G) · 3,770 shares0.0%
    Nov 16, 2026 · ↗
  • ORBIS INVESTMENT MANAGEMENT LTDSCHEDULE 13G/A · passive (13G) · 1.4M shares4.9%
    Nov 16, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 2.6M shares9.2%
    Nov 5, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 2.6M shares9.2%
    Nov 5, 2026 · ↗
  • Allan Gray Australia Pty LtdSCHEDULE 13G/A · passive (13G) · 3,108 shares0.0%
    Aug 14, 2026 · ↗
  • ORBIS INVESTMENT MANAGEMENT LTDSCHEDULE 13G/A · passive (13G) · 1.5M shares5.5%
    Aug 14, 2026 · ↗
  • Felix J. BakerSCHEDULE 13G · passive (13G) · 1.8M shares6.3%
    May 15, 2026 · ↗
  • Julian C. BakerSCHEDULE 13G · passive (13G) · 1.8M shares6.3%
    May 15, 2026 · ↗
  • Baker Bros. Advisors (GP) LLCSCHEDULE 13G · passive (13G) · 1.8M shares6.3%
    May 15, 2026 · ↗
  • Baker Bros. Advisors LPSCHEDULE 13G · passive (13G) · 1.8M shares6.3%
    May 15, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming praxis precision medicines as client
$0$125K$250K$375K$500K2023 Q1: $40K2023 Q2: $40K2023 Q3: $80K2023 Q4: $40K20232024 Q1: $30K2024 Q2: $30K2024 Q3: $30K2024 Q4: $30K20242025 Q1: $40K2025 Q2: $40K2025 Q3: $40K2025 Q4: $40K20252026 Q1: $40K2026 Q2: $80K2026 Q3: $160K2026
  • THE KPM GROUP DC LLCPRAXIS PRECISION MEDICINES · 2026 Q3 · PHA$40K
    Filing ↗
  • BALLARD PARTNERS, LLCPRAXIS PRECISION MEDICINES, INC. · 2026 Q3 · HCR$120K
    Filing ↗
  • BALLARD PARTNERSPRAXIS PRECISION MEDICINES, INC. · 2026 Q3 · HCR—
    Filing ↗
  • THE KPM GROUP DC LLCPRAXIS PRECISION MEDICINES · 2026 Q2 · PHA$40K
    Filing ↗
  • THE KPM GROUP DC LLCPRAXIS PRECISION MEDICINES · 2026 Q2 · PHA$40K
    Filing ↗

Government Contracts

Federal awards to Praxis Precision Medicines, Inc. · USAspending

No federal contract awards found for Praxis Precision Medicines, Inc..

U.S. Patents

Recent USPTO applications naming Praxis Precision Medicines, Inc.

No USPTO patent applications found for Praxis Precision Medicines, Inc..

Annual Financials

From PRAX's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$0$8.6M$2.4M$0n/a
Operating income-$326.2M-$200.2M-$126.4M-$215.0M-$167.3M
Net income-$303.3M-$182.8M-$123.3M-$214.0M-$167.1M
Diluted EPS-$13.48-$10.21-$18.69-$69.65-$3.94
Operating cash flow-$249.1M-$131.8M-$111.1M-$185.0M-$124.6M
Cash and equivalents$357.3M$215.4M$81.3M$61.6M$138.7M
Total assets$937.9M$483.1M$87.9M$115.1M$292.7M
Total liabilities$59.8M$37.7M$18.3M$39.0M$41.9M
Shareholders' equity$878.1M$445.4M$69.7M$76.1M$250.8M

As Praxis Precision Medicines, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 19, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 1-for-15Reverse splitNov 29, 2023

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsNov 12, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsNov 9, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureAug 6, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsJul 7, 2026
    EDGAR ↗
  • 8-K · Items 4.01, 9.01Change in auditorJul 2, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsJun 29, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsJun 22, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJun 12, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsJun 1, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureMay 7, 2026
    EDGAR ↗

About Praxis Precision Medicines, Inc.

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersBOSTON, MA
IncorporatedDE